The Vivitrol pilot program (VPP): initial quantitative findings from an extended-release naltrexone study

被引：0
作者：
Traci Rieckmann
Katherine T Garvey
Priya Srikanth
Laura Andrich
Jessica Gregg
机构：
[1] Oregon Health & Science University,Department of Public Health & Preventive Medicine
[2] Hooper Detoxification and Stabilization Center,undefined
来源：
Addiction Science & Clinical Practice | / 10卷 / Suppl 1期
关键词：
Medication Adherence; Naltrexone; Group Session; Opioid Dependence; Urgent Care;
D O I：
10.1186/1940-0640-10-S1-A54
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 23 条
  • [1] Extended-Release Intramuscular Naltrexone (VIVITROL®): A Review of Its Use in the Prevention of Relapse to Opioid Dependence in Detoxified Patients
    Yahiya Y. Syed
    Gillian M. Keating
    CNS Drugs, 2013, 27 : 851 - 861
  • [2] Extended-release naltrexone (XR-NTX) for opioid use disorder in clinical practice: Vivitrol's Cost and Treatment Outcomes Registry
    Saxon, Andrew J.
    Akerman, Sarah C.
    Liu, Chih-Chin
    Sullivan, Maria A.
    Silverman, Bernard L.
    Vocci, Frank J.
    ADDICTION, 2018, 113 (08) : 1477 - 1487
  • [3] Opioid treatment at release from jail using extended-release naltrexone: a pilot proof-of-concept randomized effectiveness trial
    Lee, Joshua D.
    McDonald, Ryan
    Grossman, Ellie
    McNeely, Jennifer
    Laska, Eugene
    Rotrosen, John
    Gourevitch, Marc N.
    ADDICTION, 2015, 110 (06) : 1008 - 1014
  • [4] Open-Label Pilot Study of Extended-Release Naltrexone to Reduce Drinking and Driving Among Repeat Offenders
    Lapham, Sandra C.
    McMillan, Garnett P.
    JOURNAL OF ADDICTION MEDICINE, 2011, 5 (03) : 163 - 169
  • [5] A Multisite Pilot Study of Extended-Release Injectable Naltrexone Treatment for Previously Opioid-Dependent Parolees and Probationers
    Coviello, Donna M.
    Cornish, James W.
    Lynch, Kevin G.
    Boney, Tamara Y.
    Clark, Cynthia A.
    Lee, Joshua D.
    Friedmann, Peter D.
    Nunes, Edward V.
    Kinlock, Timothy W.
    Gordon, Michael S.
    Schwartz, Robert P.
    Nuwayser, Elie S.
    O'Brien, Charles P.
    SUBSTANCE ABUSE, 2012, 33 (01) : 48 - 59
  • [6] Low-threshold extended-release naltrexone for high utilizers of public services with severe alcohol use disorder: A pilot study
    Smith-Bernardin, Shannon
    Rowe, Chris
    Behar, Emily
    Geier, Michelle
    Washington, Stuart
    Santos, Glenn-Milo
    Euren, Jason
    Martin, Judith
    Gleghorn, Alice
    Coffin, Phillip O.
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2018, 85 : 109 - 115
  • [7] Opioid use and dropout from extended-release naltrexone in a controlled trial: implications for mechanism
    Nunes, Edward, V
    Bisaga, Adam
    Krupitsky, Evgeny
    Nangia, Narinder
    Silverman, Bernard L.
    Akerman, Sarah C.
    Sullivan, Maria A.
    ADDICTION, 2020, 115 (02) : 239 - 246
  • [8] Pharmacist-Driven Alcohol Use Disorder Screening May Increase Inpatient Utilization of Extended-Release Naltrexone: A Single Center Pilot Study
    Snyder, Sabrina
    Butala, Niyati
    Williams, Andrew M.
    Kneebusch, Jamie
    PHARMACY, 2024, 12 (01)
  • [9] A pilot randomized controlled trial of medication adherence therapy: Psychosocial leverage using a significant other (MAT-PLUS) for individuals on extended-release naltrexone
    Wenzel, Kevin
    Thomas, Julia
    Carrano, Jennifer
    Stidham, Jennifer
    Fishman, Marc
    JOURNAL OF SUBSTANCE USE & ADDICTION TREATMENT, 2024, 163
  • [10] Open-label Study of Injectable Extended-release Naltrexone (XR-NTX) in Healthcare Professionals With Opioid Dependence
    Earley, Paul H.
    Zummo, Jacqueline
    Memisoglu, Asli
    Silverman, Bernard L.
    Gastfriend, David R.
    JOURNAL OF ADDICTION MEDICINE, 2017, 11 (03) : 224 - 230
123